Milberg Tadler Phillips Grossman LLP Announces Investigation of

Error. Page cannot be displayed. Please contact your service provider for more details. (14)

BioScrip, Inc.
Thursday, 08 March 2018 17:27

NEW YORK, March 8, 2018 /PRNewswire/ -- Milberg Tadler Phillips Grossman LLP, an investor protection firm, has commenced an investigation of Denver, Colorado-based BioScrip, Inc. (BIOS) regarding possible violations of federal securities laws. On March 8, 2018, BioScrip announced in its release of fourth quarter and full year financial results an ongoing internal accounting review after identifying "internal control deficiencies in connection with account reconciliations for certain asset and liability accounts."  Further, the Company disclosed that it "has identified and will report a material weakness related to certain spreadsheets used to calculate periodic adjustments to" accounts.

Read more

BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the
'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!